Prof. Patrick Tan is the Executive Director of PRECISE. As Executive Director of PRECISE, Prof Tan will oversee the implementation of Phase II of Singapore’s Precision Medicine Strategy, which aims to transform healthcare in Singapore and improve patient outcomes through new insights into the Asian genome and data-driven healthcare solutions.
During the 2020 COVID-19 pandemic, he was Program Director of Operation Stronghold, establishing one of Singapore’s largest COVID-19 testing facilities through a joint effort involving A*STAR (Agency for Science, Technology and Research), National University Health System, and Temasek Holdings.
Prof Tan is also Senior Vice Dean (Research) at Duke-NUS Medical School and Chief Scientific Officer at the Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR). He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry.
Other awards include the President’s Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), Chen New Investigator Award (Human Genome Organization), President’s Science Award, and the Japanese Cancer Association International Award. In 2018, he received the American Association for Cancer Research (AACR) Team Science Award as Team Leader, representing the first time a team from Asia has received the award. He is an elected member of the American Society for Clinical Investigation (ASCI), the Bioethics Advisory Committee (BAC), a Board Member of the International Gastric Cancer Association, and on the Board of Reviewing Editors for Science.